ClinicalTrials.Veeva

Menu

RNA Sequencing of Individual Versus Wastewater - SARS-CoV2 (Cagablea)

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

Infection Viral

Treatments

Other: NO INTERVENTION

Study type

Observational

Funder types

Other

Identifiers

NCT05041764
21DSP-IPMC01

Details and patient eligibility

About

The aim is to compare the percentage of the different SARS-CoV2 lineages that are detected in wastewater samples with matched clinical samples. About 1,400 swab samples from patients living in Nice were tested by Biogroup between Oct 19th and Oct 23rd (Week 43 of 2020). The sequence of 81 PCR positive samples, corresponding to all samples that were unambiguously assigned to one of the wastewater catchment areas and their lineage was determined. These values were compared to values measured in wastewater.

Enrollment

1,409 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • whole population tested in Nice during W43 of 2020

Exclusion criteria

  • none

Trial design

1,409 participants in 2 patient groups

PCR positive
Description:
samples that are positive for the detection of SARS-CoV2. The SARS-CoV2 sequence of positive samples is provided, together with an indication about patient's neigborhood, corresponding to one of the 21 different spots which wastewater was analyzed
Treatment:
Other: NO INTERVENTION
PCR negative
Description:
samples that are p negative for the detection of SARS-CoV2. T
Treatment:
Other: NO INTERVENTION

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems